nav-left cat-right

Canagliflozin Amputee Attorney

Since March 2013, the FDA has received more than Canagliflozin amputee attorney 70 reports of acidosis—including diabetic ketoacidosis (DKA) and ketosis—among Type 2 diabetics treated with SGLT2 inhibitors, such as Invokana and Invokamet.On September 2015, the FDA modified the drug’s label to warn patients about a possible risk of bone fractures.Its manufacturer, Johnson & Johnson, claimed it was the first diabetic medication that could lower blood sugar, blood pressure and weight at the same time.The drug is prescribed for people with Type 2 diabetes.Yet, the FDA received 20 reports of people with type 2 diabetes developing the condition between 2013 and 2014, and more reports have continued to come in since then.Untreated, type 2 diabetes can lead to serious problems, including blindness, nerve and kidney damage, and heart disease.Lawsuits filed on behalf of Invokana users will allege that the Johnson & Johnson knew or should have known about the serious side effects of Invokana before releasing it to the market.

The newest safety report is only the latest warning about Invokana and Invokamet.The Law Offices of James Scott Farrin consults with a national network of attorneys on product liability, defective drugs, and defective products cases in an attempt to provide the best representation we can for our clients.The body then begins to break down fats for energy, which releases acids (called ketones) into the bloodstream.Traces of this drug were found in the milk of lactating rats, meaning that breastfeeding mothers should talk to their doctors before taking it.Obesity and overweight are main causes of type 2 diabetes.The FDA warning suggests physicians should consider factors that predispose patients to amputations, such as prior amputations, peripheral vascular disease, neuropathy and diabetic foot ulcers, before prescribing the drug.

"  If you or a loved one has suffered an injury from this drug and want to file a invokana lawsuit, contact an experienced national invokana lawyer for a free legal consultation.An approximately two-fold increased risk of lower limb amputations associated with canagliflozin use was observed in two large, randomized, placebo-controlled trials evaluating patients with type 2 diabetes who had either established cardiovascular disease or were at risk for cardiovascular disease.An FDA ordered clinical trial found that Invokana causes bone mineral density loss at the hip and lower spine, making this drug even more dangerous to the elderly and those who already struggle with bone density issues.The active ingredient in Invokana and Invokamet is canagliflozin, which belongs to a class of drugs known as sodium-glucose co-transporter-2, or SGLT2 inhibitors.Because diabetes is a lifelong condition, choosing the best medication to control your symptoms is important.The FDA is investigating a study linking Invokana with a doubled risk of amputations in the legs and feet.The same risk was not seen in other drugs that are similar to canagliflozin.

Invokana is a prescription medicine that can help lower blood sugar in.There is no-risk and absolutely no obligation.At least two European FDA counterparts have reported that clinical trials revealed a two-fold increase in the risk of leg, foot and toe amputations.The time you have to pursue a claim is limited.

Comments are closed.